Regeneron Pharmaceuticals | Costo Del Venduto



Cost Of Sales Cambiamento Data
AbbVie USD 4.4B 184M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
Astellas Pharma JPY 98.52B 15.83B 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
J&J USD 7.11B 151M 2024-12
Kyowa Hakko Kirin JPY 34.54B 657M 2024-09
Merck USD 3.71B 181M 2024-12
Moderna USD 546M 246M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Opthea USD -148690 297.38K 2024-06
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Regeneron Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.